KORTNEY GUGUMUCK: Open Payments
NPI 1326654633 · WEST COXSACKIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 22 payments from 12 companies in 2025. Trend: 2023 $289 · 2024 $523 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $74 |
| ABBVIE INC. | 3 | $66 |
| PFIZER INC. | 2 | $50 |
| Amgen Inc. | 3 | $47 |
| Lilly USA, LLC | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Organogenesis Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $24 |
| Exeltis, USA Inc. | 1 | $21 |
Products named: AIRSUPRA, VRAYLAR, UBRELVY, OTEZLA, JARDIANCE, ELIQUIS, MOUNJARO, PURAPLY WOUND MATRIX.
Industry payments across NY — which companies pay providers there.
